L
Ligand Pharmaceuticals Incorporated (LGND)
NGM – Real vaqt narxi. Valyuta: USD
222.00
+1.52 (0.69%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
222.00
+1.52 (0.69%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Ligand Pharmaceuticals Incorporated, biotexnologik kompaniya, dunyo bo'ylab biotexnologik aktivlarni ishlab chiqadi va litsenziyalaydi. Kompaniya yuqumli kasalliklar uchun Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive va ZELSUVMI; ko'p miyelomali kasalliklar uchun EVOMELA va KYPROLIS; immünoglobulin A nefropatiyasini davolash uchun FILSPARI; bolalarda pnevmoniyaga qarshi kurashishga yordam beradigan pnevmoniyaga qarshi kon'yugatli vaktsina PNEUMOSIL; va neyroblastomani davolash uchun QARZIBAni taklif etadi. Kompaniya shuningdek, osteoporoz uchun Teriparatide in'ektsiya mahsulotini; kattalar va 8 yosh va undan katta bolalarda 2-bosqichli T1D bilan og'rigan bemorlarda 3-bosqichli 1-tip diabetning boshlanishini kechiktirish uchun ko'rsatilgan CD3ga yo'naltirilgan antitel TZIELDni; va streptokokki pnevmoniya serotiplari tomonidan chaqirilgan invaziv kasalliklarning oldini olish uchun VAXNEUVANCEni taqdim etadi. Bundan tashqari, u menopauza uchun Duavee; Nevrologiya uchun Frovatriptan; OKS uchun FYCOMPA va SESQUIENT; kardiologiya uchun MEKINIST; amiodaronning kapsulalangan formulasi Nexterone; COVID-19 uchun virusga qarshi davolash VEKLURY; va osteoporoz uchun Viviantni taklif etadi. Shuningdek, kompaniya onkologiya uchun ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL va Lasofoxifene; respirator kasalliklar uchun Ensifentrine; noyob kasalliklar uchun QTORIN; buyrak kasalliklari uchun Sparsentan; gepatologiya uchun VK2809; o'tkir kannabinoid intoksikatsiyasi uchun ANEB-001; oftalmologiya uchun Reproxalap; Noyob kasalliklar uchun VK0214; va mushkul-skelet kasalliklari uchun VK5211ni ishlab chiqadi. Kompaniya 1987 yilda tashkil etilgan va Florida shtatining Jupiter shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Karen R. Reeves M.D. | Senior VP of Investments & Head of Clinical Strategy |
| Dr. Keith Marschke Ph.D. | Senior Vice President of Biology & Scientific Affairs |
| Dr. Vincent D. Antle Ph.D. | Senior Vice President of Technical Operations & QA - Capitsol |
| Mr. Andrew T. Reardon J.D. | Chief Legal Officer & Secretary |
| Mr. Octavio Espinoza | Chief Financial Officer |
| Mr. Paul J. Hadden | Senior Vice President of Investments & Business Development |
| Mr. Richard B. Baxter | Senior VP of Investment Operations |
| Mr. Scott M. Plesha | CEO of Pelthos Therapeutics |
| Mr. Todd C. Davis Ph.D. | CEO & Director |
| Ms. Melanie J. Herman CPA | Executive Director of Investor Relations and Financial Planning & Analysis |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-08 | 10-Q | lgnd-20260331.htm |
| 2026-05-07 | 8-K | lgnd-20260507.htm |
| 2026-04-30 | 8-K | lgnd-20260424.htm |
| 2026-04-27 | DEFA14A | d143046ddefa14a.htm |
| 2026-04-27 | 8-K | d143046d8k.htm |
| 2026-04-21 | DEFA14A | ligand-2026proxysupplement.htm |
| 2026-02-27 | S-3ASR | d86418ds3asr.htm |
| 2026-02-26 | 8-K | lgnd-20260226.htm |
| 2025-12-18 | 8-K | d938301d8k.htm |
| 2025-11-07 | 10-Q | lgnd-20250930.htm |